Type I interferons in host defence and inflammatory diseases.

Area of Science:

• Immunology
• Molecular Biology
• Inflammation Research

Background:

• Type I interferons (IFN) exhibit dual roles in immunity, with transient activation being beneficial and sustained activation detrimental.
• IFN pathway dysregulation is implicated in autoimmune diseases like SLE, chronic infections, solid cancers, and myocardial infarction.
• Factors influencing IFN production and function include stimulus type, nucleic acid sensors, IFN subtype, and tissue immune ecology.

Purpose of the Study:

• To review key concepts and expert discussions on the role of Type I IFNs in inflammatory and autoimmune diseases.
• To evaluate the evidence for Type I IFN involvement across various pathological conditions.
• To highlight the need for further research into Type I IFN induction and response mechanisms.

Main Methods:

• Review of scientific literature and expert discussions from the second International Summit on Interferons in Inflammatory Diseases.
• Synthesis of current knowledge on Type I IFN biology and its clinical implications.
• Analysis of factors determining Type I IFN 'friend' or 'foe' roles in disease.

Main Results:

• Type I IFN activity can be either protective or harmful depending on its transient or sustained nature.
• The immune response to Type I IFNs is influenced by multiple biological and environmental factors.
• Dysregulated Type I IFN signaling is a common feature in various inflammatory and autoimmune conditions.

Conclusions:

• Further research is essential to elucidate the precise mechanisms of Type I IFN induction and response in diverse diseases.
• Patient endophenotyping may be critical for determining the specific role of Type I IFNs in individual cases and guiding treatment.
• The Type I IFN system represents a significant therapeutic target for inflammatory and autoimmune diseases.